Finance

Lists
MRVL:CVE
Marvel Biosciences Corp
CA$0.15
0.00%
(0.00) 1D
Sep 4, 4:00:00 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for MRVL...
Open
CA$0.15
High
CA$0.15
Low
CA$0.15
Mkt. cap
9.47M
Avg. vol.
57.68K
Volume
16.79K
52-wk high
CA$0.28
52-wk low
CA$0.12
EPS
-CA$0.03
Beta
0.22
Shares outstanding
63.03M
Open
CA$0.15
High
CA$0.15
Low
CA$0.15
Mkt. cap
9.47M
Avg. vol.
57.68K
Volume
16.79K
52-wk high
CA$0.28
52-wk low
CA$0.12
EPS
-CA$0.03
Beta
0.22
Shares outstanding
63.03M
About Marvel Biosciences Corp
CEO-
Employees-
Founded2021
HeadquartersCalgary, Alberta, Canada
SectorBiotechnology
Websitemarvelbiotechnology.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
250.56K
57.46K
5.26K
72.14K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
220.93K
189.29K
245.38K
262.03K
Operating expense
488.69K
252.83K
256.72K
340.06K
Total operating expenses
488.69K
252.83K
256.72K
340.06K
Operating income
-488.69K
-252.83K
-256.72K
-340.06K
Other non operating income
-531.64K
-10.52K
-14.17K
458.25K
EBT including unusual items
-1.19M
-342.26K
-295.58K
436.71K
EBT excluding unusual items
-1.19M
-342.26K
-295.58K
80.92K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.19M
-342.26K
-295.58K
436.71K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
72.00
-
-
-
Interest expense
-161.77K
-56.40K
-56.35K
-40.27K
Net interest expenses
-161.70K
-56.40K
-56.35K
-40.27K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps